Publications by authors named "Joline Lim"

Claim this Profile
T
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.
Sibylle Loibl, Yeon Hee Park, Zhiming Shao, Chiun-Sheng Huang, Carlos Barrios, Joline Lim

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab-deruxtecan in breast cancer treatment: Balancing the triad of efficacy, safety and accessibility.
Victor Guan Hui Lee, Joline Si Jing Lim

Ann Acad Med Singap· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.
Joan R Choo, Santhiay Nathan Jeraj, Raghav Sundar, Wei Peng Yong, Matilda Lee, Joline S J Lim

Ther Adv Med Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination.
Youjia Zhong, Jiaqi Li, Ainsley Ryan Yan Bin Lee, Janice Yu Jin Tan, Carina Jing Xuan Tay, Joline Lim

NPJ Vaccines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).
Nicholas Turner, Cristina Saura, Philippe Aftimos, Evelyn van den Tweel, Mayke Oesterholt, Joline Si Jing Lim

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia and neuropathy.
Aishwarya Bandla, Rachel Wong, Priyadharshini Santhanakrishnan, Gayathiri Magarajah, Yang En Yee, Siew Eng Lim, Joline Lim

Support Care Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience.
Victor Guan Hui Lee, Jerold Loh, Fu Hui, Raghav Sundar, Belinda Tan, Siew Eng Lim, Yi Wan Lim, Joline Si Jing Lim

Support Care Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Magnetic Field Exposure Stimulates Doxorubicin Uptake into Breast Cancer Cells in Association with TRPC1 Expression: A Precision Oncology Methodology to Enhance Chemotherapeutic Outcome.
Viresh Krishnan Sukumar, Yee Kit Tai, Ching Wan Chan, Jan Nikolas Iversen, Kwan Yu Wu, Joline Si Jing Lim

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
Robert John Walsh, Rebecca Ong, Seng Wee Cheo, Peter Q J Low, Aishwarya Jayagopal, Siew Eng Lim, Yi Wan Lim, Joline S J Lim

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
Joline S J Lim, Samuel G W Ow, Andrea L A Wong, Matilda X W Lee, Gloria H J Chan

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies.
Rachel Sj Wong, Rebecca Jm Ong, Joline Sj Lim

Cancer Drug Resist· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study.
Wei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, Ryan Ying Cong Tan, Ainsley Ryan Yan Bin Lee, Soon Thye Lim

JAMA Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.
Joseph J Zhao, Khi Yung Fong, Yiong Huak Chan, Jeremy Tey, Shaheenah Dawood, Joline S J Lim

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Cheng E Chee, Melissa Ooi, Soo-Chin Lee, Raghav Sundar, Valerie Heong, Joline S J Lim

Target Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor combinations-current and emerging strategies.
Robert J Walsh, Raghav Sundar, Joline S J Lim

Br J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
Jerold Loh, Jiaxuan Wu, Jenny Chieng, Aurora Chan, Wei-Peng Yong, Joline S J Lim

Br J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Daryl K A Chia, Raghav Sundar, Guowei Kim, Jia Jun Ang, Jeffrey H Y Lum, Joline S J Lim

Ann Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia.
Jia Li Low, Elaine Lim, Lavina Bharwani, Andrea Wong, Karmen Wong, Siew Eng Lim, Joline Lim

Ther Adv Med Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
Joline S J Lim, Andrea L A Wong, Samuel G W Ow, Natalie Y L Ngoi, Gloria H J Chan, Siew Eng Lim, Yi Wan Lim

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
Joan R E Choo, Yi-Hua Jan, Samuel G W Ow, Andrea Wong, Matilda Xinwei Lee, Joline S J Lim, Siew Eng Lim

Target Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.
Matilda Xinwei Lee, Andrea L A Wong, Samuel Ow, Raghav Sundar, David S P Tan, Joline S J Lim, Siew Eng Lim

Target Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
Kritika Yadav, Joline Lim, Joan Choo, Samuel Guan Wei Ow, Andrea Wong, Siew Eng Lim

Breast Cancer Res Treat· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alliance-Outcome Association in Couple Therapy: A Common Fate Model.
Kelley Quirk, Joanna M Drinane, Anna Edelman, Daryl Chow, Joline Lim

Fam Process· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in -Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.
Javier Pascual, Joline S J Lim, Iain R Macpherson, Anne C Armstrong, Alistair Ring

Cancer Discov· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
Yvonne L E Ang, Gwo Fuang Ho, Ross A Soo, Raghav Sundar, Sing Huang Tan, Joline S J Lim

BMC Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis